Current filters:


Popular Filters

8401 to 8425 of 8833 results

German pharma counts cost of drug pricing reforms


Recent government drug pricing reforms have cost the German pharmaceutical industry billions of euros,…


Teva buys out partner Kowa’s interest in Japanese JV for $150 million


Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world’s largest generic drugmaker,…

Asia-PacificGenericsKowa PharmaceuticalsMergers & AcquisitionsTeva Pharmaceutical Industries

Marina Biotech’s intranasal insulin delivery formulations for sale


A patent portfolio related to rapid-acting intranasal (IN) insulin delivery formulations, which is owned…

DiabetesLicensingMarina BiotechNeurologicalPatentsPharmaceuticalResearch

ALK-Abello reveals progress with Mitizax in Japan and Europe


Denmark’s ALK-Abello (ALKB: DC) says that its partner, Japanese drugmaker Torii Pharmaceuticals…

Alk-AbelloMitizaxPharmaceuticalResearchRespiratory and PulmonaryTorii Pharma

Medicines Australia starts new Code of Conduct review


Pharma trade group Medicines Australia has commenced a Review of its Code of Conduct and invites public…

Asia-PacificGlaxoSmithKlineMarkets & MarketingPharmaceuticalRegulation

EMA advisory panel backs Bayer’s Xarelto for AF-related stroke prevention and DVT


There was more good news for Bayer HealthCare, the pharma unit of Germany’s Bayer AG (BAY: DE),…


US leadership in global biomedical industry vulnerable to international competition


The USA still holds a commanding position in the biomedical field, but countries across Europe and Asia…

BiotechnologyFinancialNorth AmericaPharmaceuticalResearch

Positive first Phase III trial of an alpha-pharmaceutical, Bayer’s Alpharadin


Until recently, options for patients with bone metastases from advanced prostate cancer have been very…


Novartis cancer drug imatinib shows efficacy in PAH


Swiss drug major Novartis (NOVN: VX) yesterday announced new data today at the European Respiratory Society…

ActelionCardio-vascularImatinib MesylateNovartisPharmaceuticalResearchRespiratory and PulmonaryTracleer

PharmAthene awarded 50% profit split on SIGA smallpox drug


USA-based PharmAthene (NYSE Amex: PIP) last week won a significant decision in its litigation against…

Anti-viralsFinancialLegalNorth AmericaPharmaceuticalPharmAtheneSIGA Technologies

USA’s GPhA calls on “Super Committee” to pursue policies encouraging use of generic drugs


The US Generic Pharmaceutical Association (GPhA) says it has sent a letter to Co-Chairs Senator Patty…

GenericsNorth AmericaPoliticsRegulation

Sth Africa’s Litha Healthcare teams with Natco for generics marketing in India


South Africa-based Litha Healthcare Group has signed an exclusive agreement with Indian generic drugmaker…

Asia-PacificFinancialGenericsLitha HealthcareMarkets & MarketingNatco Pharma

Generic erosion to weigh on unipolar depression drug market


Owing to the generic erosion of blockbuster agents, the unipolar depression drug market - which includes…

GlobalMarkets & MarketingNeurologicalPharmaceutical

EMA recommends restricting use of Sanofi AF drug Multaq, but sees positive benefit-risk in some patients


There was mixed news for French drug major Sanofi (Euronext: SAN) yesterday, when the European Medicines…


German drug pricing reforms lower health system’s costs, says AVR report


The multi-year uptrend in drug expenditure by Germany’s health insurers could be ending, according…


Bristol-Myers teams up with Ambrx for novel biologics programs in diabetes and heart failure


US drug major Bristol-Myers Squibb (NYSE: BMY) revealed yesterday that it has teamed up with privately-held…

AmbrxBristol-Myers SquibbCardio-vascularDiabetesLicensingPharmaceutical

Use of generic Rx drugs saved US consumers and the health care system $931 billion over past 10 years, study finds


An independently conducted analysis showing that the use of generic prescription drugs in the USA has…

GenericsMarkets & MarketingNorth AmericaPricing

8401 to 8425 of 8833 results

Back to top